Market Research Industry Reports

Natera Inc (NTRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the companys algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Partnerships 15
Natera Enters into Agreement with Imperial College London and University of Leicester 15
Natera Enters into Research Agreement with University of California, San Francisco 16
Equity Offering 17
Natera Prices Public Offering of Shares for USD90 Million 17
Natera Raises USD180 Million in IPO 19
Natera Inc - Key Competitors 21
Natera Inc - Key Employees 22
Natera Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Jan 04, 2017: Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening 24
Financial Announcements 25
Aug 08, 2018: Natera reports second quarter 2018 financial results 25
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 27
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 29
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 31
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 33
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 35
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 37
Corporate Communications 39
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 39
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 40
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 41
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables


Natera Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Natera Enters into Agreement with Imperial College London and University of Leicester 15
Natera Enters into Research Agreement with University of California, San Francisco 16
Natera Prices Public Offering of Shares for USD90 Million 17
Natera Raises USD180 Million in IPO 19
Natera Inc, Key Competitors 21
Natera Inc, Key Employees 22
Natera Inc, Subsidiaries 23

List Of Figures


Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9

Natera Inc (NTRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 250View Report

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 750View Report

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 750View Report

Natera Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Natera Inc Company Profile is a detailed strategic and analytical report on Natera Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2018
No. of Pages :43
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube